Progen, Cytopia, Avexa, Acrux, Biota, Cellestis [ + ]

Mesoblast raises $10 million from new and existing investors [ + ]

ChemGenex’ lead candidate kills cancer stem cells in animal model [ + ]

Viralytics granted patent in US for oncolytic echoviruses [ + ]

TGR BioSciences CSO Michael Crouch wins Advancing BioBusiness Award [ + ]

Biota’s partner Daiichi Sankyo applies for marketing licence, finishes Phase III enrolment [ + ]

Cochlear, CSL, Progen, Genera Biosystems, Peplin [ + ]

16 new fellows elected to Australian Academy of Science [ + ]

DNA testing to establish the breed of pet dogs is now commercially available in Australia.

The 'What's Your Problem New Zealand?' competition gives New Zealand enterprises, big or small, the chance to win up to $1 million in research and development services from one of New Zealand’s leading technology partners.

A significant proportion of drugs consumed in the developing world are of poor quality, many of which are counterfeit, according to a group of international experts who have published guidelines to help detect these questionable drugs.

Female finches bias the gender of offspring depending on head colour [ + ]

Johns Hopkins engineers have invented a lab-on-a-chip that could be used to help discern how cancer cells detach from neighbouring tissue and spread throughout the body.

CSL, Cochlear, Resmed, Genera, Starpharma, Novogen [ + ]

Alchemia in deal with private firm SDP for sphingosine kinase 1 target [ + ]